All changes for the tissue kidney (130)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA267
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein
Molecular
kidney
Human
APBB1IP
23.0% Increase Gene Expression Level
DAA262
kelch-like 3 (Drosophila)
Molecular
kidney
Human
KLHL3
14.0% Decrease Gene Expression Level
DAA285
immunoglobulin kappa variable 1-5
Molecular
kidney
Human
IGKV1-5
35.0% Increase Gene Expression Level
DAA620
Hypertensive heart and renal disease
Pathological
heart, kidney
Human
—
SeriesMorbidity
DAA274
immunoglobulin lambda variable 3-25
Molecular
kidney
Human
IGLV3-25
46.0% Increase Gene Expression Level
DAA280
FXYD domain containing ion transport regulator 2
Molecular
kidney
Human
FXYD2
5.0% Decrease Gene Expression Level
DAA288
complement component 1, r subcomponent
Molecular
kidney
Human
C1R
21.0% Increase Gene Expression Level
DAA626
Essential (primary) hypertension and hypertensive renal disease
Pathological
heart, kidney
Human
—
SeriesMorbidity
DAA270
lipoprotein lipase
Molecular
kidney
Human
LPL
17.0% Decrease Gene Expression Level
DAA271
epidermal growth factor (beta-urogastrone)
Molecular
kidney
Human
EGF
25.0% Decrease Gene Expression Level
DAA275
complement component 1, q subcomponent, C chain
Molecular
kidney
Human
C1QC
27.0% Increase Gene Expression Level
DAA283
lactotransferrin
Molecular
kidney
Human
LTF
115.0% Increase Gene Expression Level
DAA257
kininogen 1
Molecular
kidney
Human
KNG1
17.0% Decrease Gene Expression Level
DAA258
EF-hand domain family, member D1
Molecular
kidney
Human
EFHD1
9.0% Decrease Gene Expression Level
DAA290
lysozyme (renal amyloidosis)
Molecular
kidney
Human
LYZ
57.0% Increase Gene Expression Level
DAA266
matrix metallopeptidase 7 (matrilysin, uterine)
Molecular
kidney
Human
MMP7
23.0% Increase Gene Expression Level
DAA2026
Mutations in mitochondrial DNA accumulate
Physiological
heart, kidney, skeletal muscle, cerebral cortex, cerebellum
Human
—
—
DAA894
Interstitial fibrosis in medulla
Physiological
kidney
Human
—
—
DAA279
nicotinamide N-methyltransferase
Molecular
kidney
Human
NNMT
40.0% Increase Gene Expression Level
DAA264
paraoxonase 3
Molecular
kidney
Human
PON3
13.0% Decrease Gene Expression Level
DAA259
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides
Molecular
kidney
Human
IGJ
60.0% Increase Gene Expression Level
DAA278
Ras-related GTP binding D
Molecular
kidney
Human
RRAGD
14.0% Decrease Gene Expression Level
DAA2020
Reduction in renal function
Physiological
kidney
Human
—
—
DAA256
defensin, beta 1
Molecular
kidney
Human
DEFB1
8.0% Decrease Gene Expression Level
DAA281
coiled-coil domain containing 3
Molecular
kidney
Human
CCDC3
19.0% Increase Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA267 | amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein | Molecular | kidney | Human | APBB1IP | 23.0% Increase Gene Expression Level | |
DAA262 | kelch-like 3 (Drosophila) | Molecular | kidney | Human | KLHL3 | 14.0% Decrease Gene Expression Level | |
DAA285 | immunoglobulin kappa variable 1-5 | Molecular | kidney | Human | IGKV1-5 | 35.0% Increase Gene Expression Level | |
DAA620 | Hypertensive heart and renal disease | Pathological | heart, kidney | Human | — | SeriesMorbidity | |
DAA274 | immunoglobulin lambda variable 3-25 | Molecular | kidney | Human | IGLV3-25 | 46.0% Increase Gene Expression Level | |
DAA280 | FXYD domain containing ion transport regulator 2 | Molecular | kidney | Human | FXYD2 | 5.0% Decrease Gene Expression Level | |
DAA288 | complement component 1, r subcomponent | Molecular | kidney | Human | C1R | 21.0% Increase Gene Expression Level | |
DAA626 | Essential (primary) hypertension and hypertensive renal disease | Pathological | heart, kidney | Human | — | SeriesMorbidity | |
DAA270 | lipoprotein lipase | Molecular | kidney | Human | LPL | 17.0% Decrease Gene Expression Level | |
DAA271 | epidermal growth factor (beta-urogastrone) | Molecular | kidney | Human | EGF | 25.0% Decrease Gene Expression Level | |
DAA275 | complement component 1, q subcomponent, C chain | Molecular | kidney | Human | C1QC | 27.0% Increase Gene Expression Level | |
DAA283 | lactotransferrin | Molecular | kidney | Human | LTF | 115.0% Increase Gene Expression Level | |
DAA257 | kininogen 1 | Molecular | kidney | Human | KNG1 | 17.0% Decrease Gene Expression Level | |
DAA258 | EF-hand domain family, member D1 | Molecular | kidney | Human | EFHD1 | 9.0% Decrease Gene Expression Level | |
DAA290 | lysozyme (renal amyloidosis) | Molecular | kidney | Human | LYZ | 57.0% Increase Gene Expression Level | |
DAA266 | matrix metallopeptidase 7 (matrilysin, uterine) | Molecular | kidney | Human | MMP7 | 23.0% Increase Gene Expression Level | |
DAA2026 | Mutations in mitochondrial DNA accumulate | Physiological | heart, kidney, skeletal muscle, cerebral cortex, cerebellum | Human | — | — | |
DAA894 | Interstitial fibrosis in medulla | Physiological | kidney | Human | — | — | |
DAA279 | nicotinamide N-methyltransferase | Molecular | kidney | Human | NNMT | 40.0% Increase Gene Expression Level | |
DAA264 | paraoxonase 3 | Molecular | kidney | Human | PON3 | 13.0% Decrease Gene Expression Level | |
DAA259 | immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides | Molecular | kidney | Human | IGJ | 60.0% Increase Gene Expression Level | |
DAA278 | Ras-related GTP binding D | Molecular | kidney | Human | RRAGD | 14.0% Decrease Gene Expression Level | |
DAA2020 | Reduction in renal function | Physiological | kidney | Human | — | — | |
DAA256 | defensin, beta 1 | Molecular | kidney | Human | DEFB1 | 8.0% Decrease Gene Expression Level | |
DAA281 | coiled-coil domain containing 3 | Molecular | kidney | Human | CCDC3 | 19.0% Increase Gene Expression Level |